Your browser doesn't support javascript.
loading
Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma.
Sun, Hao; Liu, Si-Yang; Zhou, Jia-Ying; Xu, Jin-Tian; Zhang, Huang-Kai; Yan, Hong-Hong; Huan, Jiao-Jiao; Dai, Ping-Ping; Xu, Chong-Rui; Su, Jian; Guan, Yan-Fang; Yi, Xin; Yu, Rong-Shan; Zhong, Wen-Zhao; Wu, Yi-Long.
Affiliation
  • Sun H; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou 510080, China.
  • Liu SY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou 510080, China.
  • Zhou JY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou 510080, China.
  • Xu JT; Aginome Scientific Co., Ltd., Xiamen, China.
  • Zhang HK; Aginome Scientific Co., Ltd., Xiamen, China.
  • Yan HH; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou 510080, China.
  • Huan JJ; Geneplus-Beijing Institute, Beijing, China.
  • Dai PP; Geneplus-Beijing Institute, Beijing, China.
  • Xu CR; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou 510080, China.
  • Su J; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou 510080, China.
  • Guan YF; Geneplus-Beijing Institute, Beijing, China.
  • Yi X; Geneplus-Beijing Institute, Beijing, China.
  • Yu RS; Aginome Scientific Co., Ltd., Xiamen, China; AmoyDx-XMU Joint Lab, School of Informatics, Xiamen university, Xiamen, China.
  • Zhong WZ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou 510080, China.
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou 510080, China. Electronic address: syylwu@live.cn.
EBioMedicine ; 60: 102990, 2020 Oct.
Article in En | MEDLINE | ID: mdl-32927274
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Tumor Suppressor Protein p53 / Adenocarcinoma of Lung / Mutation Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: EBioMedicine Year: 2020 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Tumor Suppressor Protein p53 / Adenocarcinoma of Lung / Mutation Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: EBioMedicine Year: 2020 Type: Article Affiliation country: China